The American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA, was held on the 1–4 December.
Explore the news from big trials, updates from key pivotal studies, exciting discoveries in disease biology, as well as the latest CAR T-cell data and MRD insights, and late-breaking abstracts.
Watch the press briefs and late-breaking abstracts.
Big trials with big results, new and novel agents, CAR T-cell therapies, non-malignant pathologies, and pivotal study updates.
The latest CAR T-cell data is here, and we’re seeing lots of new exciting agents on the horizon.
Find out all the news from recently approved treatments, as well as the most promising new CARs in the hematology arena, here.
The assessment of MRD status has gone from strength to strength.
At ASH we spoke to world-leading experts about the latest on MRD-guided treatment, NGS vs. MFC for measurement, and more.
Your definitive guide to multiple myeloma at ASH 2018.
Covering the latest trial data, transplant updates, MRD, CAR-T and BiTEs, promising novel agents, and beyond.